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in particular, the rotational atherectomy and cutting balloon, this
group of patients can be treated with percutaneous intervention. This
study was to review the safety and efﬁcacy of rotablator and cutting
balloon in our practice.
METHODS From January 2012 to December 2013, all consecutive pa-
tients who received rotational atherectomy for heavily calciﬁed left
main coronary disease in our cath lab were enrolled. All clinical and
angiographic characteristics as well as information regarding rota-
tional atherectomy and cutting balloon were retrieved and analyzed.
RESULTS A total number of 8 patients were recruited with a mean age
77.6 +/- 9. There were 75% presented with stable angina, 12.5% with
acute coronary syndrome and 12.5% with cardiogenic shock. Chronic
renal disease was seen in 25%, diabetes mellitus in 50% and hyper-
tension in 100%. The angiographic and procedural success rate was
100%. The number of burrs used per patient was 1.3+/-0.4 and burr
size was 1.75+/-0.25. The cutting balloon size was 2.34+/-0.7. Most
stents were drug-eluting stent 87%. The techniques used for bifur-
cation stenting were culotte (62.5%), mini-crush (25%) and provisional
(12.5%). Intra-aortic balloon pump was used in 25%. There was no
complication among our cases.
CONCLUSION Heavily calciﬁed left main coronary disease treated
with rotational atherectomy, cutting balloon and stent is feasible and
safe with high angiographic and procedural success rate.
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BACKGROUND The mortality of patients (pts) admitted with acute
myocardial infarction (AMI) remains high despite improvement in all
aspects of cardiac care. This mortality is even higher in pts who
require index left main (LM) revascularization at the time of admis-
sion. We sought to investigate the predictors of in-hospital and 2-year
mortality in such pts.
METHODS This study is single center, retrospective, observational
and registry-based study. All pts admitted for AMI as deﬁned in the
“Third Universal Deﬁnition of Myocardial Infarction” and fulﬁlled the
inclusion and exclusion criteria was enrolled. A total of 212 AMI pts
were screened from our institutional LM stenting registry and we
identiﬁed 75 pts among this cohort who successfully underwent
emergency revascularization of the LM disease.
RESULTS A total of 75 AMI pts with signiﬁcant LM disease were
enrolled. Male was in 77.3%. There were 47 (62.7%) ST-segment
elevation myocardial infarction (STEMI). Cardiogenic shock was pre-
sent in 12.0% of the pts and signiﬁcant number of pts required IABP
insertion. Clinical and Angiographic success was achieved in 100% of
the patients. Overall, the in-hospital mortality remained high at 17.3%
due to overt heart failure, cardiogenic shock and multi-organs func-
tion. 13 Major cardiovascular events (MACE) were recorded during
hospitalization including death, myocardial infarction, and stent
thrombosis and target vessel revascularization. From the multiple
regression analysis, cardiogenic shock at presentation and the renal
dysfunction remained a good predictor of in-hospital and 2-year
mortality for in-hospital survivors. Prognosis for pts in cardiogenic
shock remained grave with 77.8% of in-hospital mortality. At 2-year
follow up, in-hospital survivor has a mortality of 11.3%whereas addi-
tional 22 experienced MACE.
CONCLUSION Pts with LM disease required stenting at the time of
AMI is uncommon but is associated with high in-hospital and 2-years
mortality especially in those presenting with cardiogenic shock and
renal dysfunction.TCTAP A-039
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BACKGROUND Final kissing balloon inﬂation (KBI) is generally
accepted as a technique to expand the side branch (SB) and proximal
main vessel (MV) simultaneously after cross-over stenting in the
coronary bifurcation lesion. The prior bench testing, however,
revealed that the KBI causes an asymmetric oval deformation of the
proximal MV stent. The Glider balloon (GB) (Tri Reme Medical,
Pleasanton, CA, U.S.A) is a dedicated SB balloon designed for optimal
SB ostial expansion with minimizing the MV stent deformation. We
investigated the efﬁcacy of the GB in the present study.
METHODS We analyzed consecutive 19 patients who undertook
elective bifurcation stenting with SB dilation using the GB and prox-
imal optimization technique (POT) (mean age; 71  2 year-old, man /
female ¼ 17 / 2). The lesion location was LMT / LAD / LCx / RCA ¼ 9 / 7 /
1 / 2. The 2.5 / 4 mm and 3.0/ 4 mm GB balloons were used in 12 and 7
cases, respectively. We evaluated the eccentricity index (short / long
lumen diameter) and cross sectional area (CSA) in the SB ostium,
proximal and distal MV at the bifurcation and the reference sites using
IVUS or OCT or OFDI.
RESULTS The eccentricity index at the bifurcation site was not statis-
tically different from that at the reference site in each branch (distalMV;
0.900.01 vs. 0.900.01, SB; 0.860.02 vs. 0.880.02, proximalMV;
0.89  0.01 vs. 0.91  0.01, versus reference site). In addition, the CSA
was not statistically different in each site compared with that of each
reference site (distal MV; 7.77 0.53 vs. 7.33 0.51 mm2, SB; 6.67 0.73
vs. 5.74  0.52 mm2, proximal MV; 8.94  0.47 vs. 9.79  0.61 mm2,
versus reference site). The mean percentage of lumen CSA gain of the
proximal MV compared to the distal MVwas 388%, which was similar
as that induced by the KBI in the previous report.
CONCLUSION These data indicate that the SB dilatation by the GB
combined with POT could provide symmetrical and sufﬁcient
expansion in each branch without any signiﬁcant deformation of the
MV stent.
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BACKGROUND Percutaneous coronary interventions with standard
balloon or bare metal stent for bifurcational lesion carry a signiﬁcant
restenosis rate of both vessels. The use of the drug eluting stent (DES)
